MX360450B - Mejoras de y relacionadas con composiciones. - Google Patents

Mejoras de y relacionadas con composiciones.

Info

Publication number
MX360450B
MX360450B MX2013008635A MX2013008635A MX360450B MX 360450 B MX360450 B MX 360450B MX 2013008635 A MX2013008635 A MX 2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A MX 360450 B MX360450 B MX 360450B
Authority
MX
Mexico
Prior art keywords
preserved
relating
compositions
solutions
constipation
Prior art date
Application number
MX2013008635A
Other languages
English (en)
Spanish (es)
Other versions
MX2013008635A (es
Inventor
Seldon Chris
Padfield Dawn
Morrissey Frances
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of MX2013008635A publication Critical patent/MX2013008635A/es
Publication of MX360450B publication Critical patent/MX360450B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX2013008635A 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones. MX360450B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Publications (2)

Publication Number Publication Date
MX2013008635A MX2013008635A (es) 2013-11-04
MX360450B true MX360450B (es) 2018-11-01

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008635A MX360450B (es) 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones.

Country Status (17)

Country Link
EP (2) EP2862566B1 (enExample)
JP (2) JP2014504628A (enExample)
KR (1) KR101852502B1 (enExample)
CN (2) CN103458874A (enExample)
AU (1) AU2012213180B2 (enExample)
BR (1) BR112013019418B1 (enExample)
CY (1) CY1125270T1 (enExample)
DE (1) DE202012013349U1 (enExample)
DK (1) DK2862566T3 (enExample)
EA (1) EA028925B1 (enExample)
ES (1) ES2914034T3 (enExample)
HR (1) HRP20220691T1 (enExample)
MX (1) MX360450B (enExample)
PL (1) PL2862566T3 (enExample)
PT (1) PT2862566T (enExample)
WO (1) WO2012104617A1 (enExample)
ZA (1) ZA201305342B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
BR112015005270B1 (pt) 2012-09-11 2022-11-01 Norgine Bv Composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения
WO2016208781A1 (ko) * 2015-06-22 2016-12-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002335900A1 (en) * 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Also Published As

Publication number Publication date
ZA201305342B (en) 2014-12-23
BR112013019418A2 (enExample) 2017-08-29
EA028925B1 (ru) 2018-01-31
AU2012213180B2 (en) 2017-04-13
JP2018035181A (ja) 2018-03-08
CN103458874A (zh) 2013-12-18
BR112013019418B1 (pt) 2022-03-29
EA201300882A1 (ru) 2014-01-30
KR101852502B1 (ko) 2018-04-26
DK2862566T3 (da) 2022-05-16
EP2670391A1 (en) 2013-12-11
ES2914034T3 (es) 2022-06-07
WO2012104617A1 (en) 2012-08-09
PL2862566T3 (pl) 2022-06-20
EP2862566B1 (en) 2022-03-09
MX2013008635A (es) 2013-11-04
JP2014504628A (ja) 2014-02-24
EP2862566A1 (en) 2015-04-22
CN107260661A (zh) 2017-10-20
NZ613401A (en) 2016-03-31
DE202012013349U1 (de) 2016-06-27
HRP20220691T1 (hr) 2022-07-08
JP6498250B2 (ja) 2019-04-10
CY1125270T1 (el) 2024-12-13
PT2862566T (pt) 2022-06-02
KR20140007881A (ko) 2014-01-20

Similar Documents

Publication Publication Date Title
TW201129570A (en) Spiro-oxindole MDM2 antagonists
PH12013500955A1 (en) Spiro-oxindole mdm2 antagonists
PH12015501336A1 (en) Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
WO2012033789A3 (en) Treatment of diseases
IN2015DN02729A (enExample)
MX2013004061A (es) Analogos de ciclosporina.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
CA2801009C (en) Native wharton's jelly stem cells and their purification
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
CY1125270T1 (el) Βελτιωσεις σε και σχετιζομενες με συνθεσεις
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
PH12013501365A1 (en) Glycols as pathogen inactivating agents
EP2583969A4 (en) NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
MX2013004062A (es) Analogos de ciclosporina.
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
WO2012097272A8 (en) Stable hydrogel compositions including additives
WO2013055889A3 (en) Implantable scaffolds and methods of use
HK1216504A1 (zh) 疾病的治療方法
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole
AR089615A1 (es) Peptidos antimicrobianos, composiciones que los comprenden y usos
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
PH12012502054A1 (en) Dithiinopyridazine-dion derivatives
TN2011000352A1 (en) New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative

Legal Events

Date Code Title Description
FG Grant or registration